![]() |
||||||||||
|
||||||||||
| |
Gerald
Nepom's Web Page at BRI Projects in Dr. Nepom's laboratory are focused on identifying and understanding molecular and genetic mechanisms contributing to triggering of autoimmune disorders. A combination of in vitro studies, preclinical models, and human T cell profiling is used to evaluate autoreactive T cell lineage and fate determination. Translational and clinical applications include evaluation of the role of HLA class II genes in the etiology of type I diabetes and adult and juvenile rheumatoid arthritis, and use of immunological monitoring tools for predicting disease susceptibility and response to therapy in clinical trials. Recent publications: Bollyky PL, Lord JD, Masewicz SA, Evanko SP, Buckner JH, Wight T, and Nepom GT. Cutting edge: High molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. J Immunol 179: 744–747, 2007. PMID: 17617562. von Herrath M, Nepom GT. Animal models of human type 1 diabetes. Nat Immunol 10:129-132, 2009. PMID: 19148193. Long SA, Walker MR, Rieck M, James EA, Kwok WW, Sanda S, Pihoker C, Greenbaum CJ, Nepom GT, Buckner JH. Functional islet-specific Treg can be generated from CD4+ CD25- T cells of healthy and type 1 diabetic subjects. Eur J Immunol 39:612-620, 2009. PMID: 19180473. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 360:1646-1654, 2009. PMID: 19369670. Gebe JA, Yue BB, Unrath KA, Falk BA, Nepom GT. Restricted autoantigen recognition associated with deletional and adaptive regulatory mechanisms. J Immunol 183:59-65, 2009. PMID: 19535636. .
Medline
database search for this researcher
|
||||||||
| Copyright © 2001-2002 University of Washington. All Rights Reserved. |